These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 26059506
1. Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka. Ellepola AN, Jayathilake JA, Sharma PN, Khan ZU. J Investig Clin Dent; 2016 Nov; 7(4):424-430. PubMed ID: 26059506 [Abstract] [Full Text] [Related]
2. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans. Ellepola AN, Khajah R, Jayatilake S, Samaranayake L, Sharma P, Khan Z. J Appl Oral Sci; 2015 Nov; 23(4):412-8. PubMed ID: 26398514 [Abstract] [Full Text] [Related]
4. Impact of Brief Exposure to Drugs with Antifungal Properties on the Susceptibility of Oral Candida dubliniensis Isolates to Lysozyme and Lactoferrin. Ellepola ANB, Dassanayake RS, Khan Z. Med Princ Pract; 2018 Nov; 27(6):523-530. PubMed ID: 30173211 [Abstract] [Full Text] [Related]
5. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates. Ellepola AN, Joseph BK, Samaranayake LP, Bandara HM, Khan ZU. J Investig Clin Dent; 2016 May; 7(2):149-57. PubMed ID: 25388637 [Abstract] [Full Text] [Related]
7. In vitro adhesion of oral Candida dubliniensis isolates to acrylic denture surfaces following brief exposure to sub-cidal concentrations of polyenes, azoles and chlorhexidine. Ellepola AN, Joseph BK, Altarakemah Y, Samaranayake LP, Anil S, Hashem M, Khan ZU. Med Princ Pract; 2015 May; 24(1):58-64. PubMed ID: 25471106 [Abstract] [Full Text] [Related]
12. The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. Ellepola AN, Joseph BK, Chandy R, Khan ZU. Mycoses; 2014 Jan; 57(1):56-63. PubMed ID: 23773155 [Abstract] [Full Text] [Related]
14. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Quindós G, Carrillo-Muñoz AJ, Arévalo MP, Salgado J, Alonso-Vargas R, Rodrigo JM, Ruesga MT, Valverde A, Pemán J, Cantón E, Martín-Mazuelos E, Pontón J. Chemotherapy; 2000 Jan; 46(6):395-401. PubMed ID: 11053905 [Abstract] [Full Text] [Related]
15. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Pfaller MA, Messer SA, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR. J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880 [Abstract] [Full Text] [Related]
16. In vitro postantifungal effect, adhesion traits and haemolysin production of Candida dubliniensis isolates following exposure to 5-fluorocytosine. Ellepola AN, Chandy R, Khan ZU. Mycoses; 2015 Sep; 58(9):536-43. PubMed ID: 26201447 [Abstract] [Full Text] [Related]
17. Impact of Cigarette Smoke Condensate on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates. Ellepola ANB, Khan ZU. Mycopathologia; 2020 Apr; 185(2):289-297. PubMed ID: 31792662 [Abstract] [Full Text] [Related]
18. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC. Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003 [Abstract] [Full Text] [Related]